Eurosurveillance banner


Eurosurveillance is planning to publish a special issue on Socio-economic determinants and infections diseases in Europe in spring of 2010. For this reason Eurosurveillance invites interested scientists who have research findings in the area to submit papers for review and possible publication.

The data from 27 European Union countries plus Iceland, Liechtenstein and Norway show that considerable progress has been made in preventing and controlling the disease. The number of newly diagnosed cases and the overall notification rate declined continuously in the past decade, and the notification rate in 2007 was 12% lower than in 2003. In spite of this decline, a total of 84,917 new cases of TB were registered in 2007 and a number of challenges hamper the progress towards the elimination of TB in the EU.

A number of bacterial and viral infections in pregnant women can have serious effects on the unborn child leading to impaired mental and physical health later in life. This week’s issue of Eurosurveillance is dedicated to infectious diseases in pregnancy.

The emergence and spread of antimicrobial resistance (AMR) is a growing problem in many European countries. To mark the very first European Antibiotic Awareness Day, on 18 November, the scientific journal Eurosurveillance runs a series of articles to highlight main aspects of the AMR problem in Europe. They will be published in two issues on 13 and 20 November 2008.

In preparation for the coming influenza season 2008-9, Eurosurveillance publishes a special issue on prevention of influenza by vaccination. Seasonal influenza poses a serious public health threat because of associated serious morbidity and mortality. In Europe, estimates suggest that influenza is responsible for around 40,000 to 220,000 excess deaths, depending on the severity of the epidemic.

Today Eurosurveillance is publishing a special issue dedicated to the widespread advances made in Europe in estimating the real number of newly acquired HIV infections based on an innovative approach called STARHS

To tie in with World Hepatitis Day on 19 May, the scientific journal Eurosurveillance is today publishing a special issue on viral hepatitis, highlighting issues and challenges related to hepatitis B and C.

On 17 April 2008, Eurosurveillance is publishing a special issue with articles on the measles situation in Europe. The publication is linked to European Immunisation Week which runs from 21-27 April.

World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings of the causing agent of tuberculosis (TB) – Mycobacterium tuberculosis. In the run up of this day Eurosurveillance publishes a special issue on the situation of TB in Europe.

Today (6 March, 2008), Eurosurveillance, the European peer-reviewed journal of infectious diseases, publishes a special issue on meningococcal disease. It includes two in-depth articles and an editorial by the European Centre for Disease Prevention and Control (ECDC).


In this issue


Home Eurosurveillance Monthly Release  2004: Volume 9/ Issue 2 Article 1 Printer friendly version
Back to Table of Contents
en es fr it pt
Next

Eurosurveillance, Volume 9, Issue 2, 01 February 2004
Editorial
European Surveillance of Travel Associated Legionnaires' Disease

Citation style for this article: Joseph C. European Surveillance of Travel Associated Legionnaires' Disease. Euro Surveill. 2004;9(2):pii=443. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=443

Carol Joseph, EWGLINET project coordinator, HPA, CDSC, London, UK

 



Disease acquired in one country but diagnosed and reported in another, necessitates international cooperation if it is to be controlled, investigated and further cases prevented. The European surveillance scheme for travel associated legionnaires' disease (EWGLINET) was established in 1987 to operate in this type of context and has been highly active in sharing information and coordinating its actions since then. In July 2002 European guidelines were introduced by EWGLINET that have standardised the response to clusters across most countries in Europe. Three papers presented in this special issue show how the guidelines have been successfully adopted in France (1), Italy (2) and Spain (3), despite the additional workload associated with their implementation. The paper from the coordinating centre in London provides an overview of EWGLINET results in 2002.

Tourism is a major industry in many European countries and sensitive to health threats. In France and Spain around 77 million and 40 million persons respectively are estimated to visit annually, with similar high numbers reported to visit Italy. The resident population in each of these countries also adds to the high number of tourists each year. The importance of reporting cases of legionnaires' disease in indigenous travellers to EWGLINET is borne out by the fact that Italy and Spain respectively reported that 54% and 40.6% of their clusters included both indigenous and foreign persons. In France only 24% of the clusters were reported to include both French and non-French tourists, with most comprising French nationals only, reflecting the very high number of indigenous travellers in that country. Clusters constituting cases from more than one country would presumably have remained undetected had there been no international reporting and follow up collaborations through the EWGLINET scheme.

The control and prevention of travel associated legionnaires' disease depends on international collaborations and the good will of national authorities to provide the resources and expertise for best public health to be practiced. Once clusters are detected, investigating the environmental source of infection is relatively straightforward since the accommodation site used by the cases is normally the focus point, supported by epidemiological data. The rapid response by the country of infection also results in the majority of hotel-associated clusters comprising less than four cases each. In contrast, non-travel associated legionella outbreaks, ie those that have a source of infection mainly affecting a population within a widespread geographical area may be much more difficult to investigate and control and frequently involve a large number of cases. The French health authorities have recently been confronted with such an outbreak and its control. It is the first time that an industrial cooling tower is implicated in an outbreak in France. The cooling tower of the chemical plant was incriminated as the most likely source of this prolonged common source outbreak. The cleaning and disinfection interventions on the cooling tower may have played a role in continuation of the environment, after closing of the plant, contributing to the prolonged course of the outbreak. However, more than one source of infection has been noted in community outbreaks elsewhere.

Non-travel associated outbreaks may be politically sensitive for the country concerned but require national legislation for control and prevention. Travel associated legionella outbreaks require international actions and to this end all collaborating countries in EWGLINET are committed to the goal of improving health protection for travellers. All parties involved in tourism and international aspects of public health value EWGLINET's unique role in this process.
 


References

1. Decludt B, Campese C, Lacoste M, Che D, Jarraud S, Etienne J. Clusters of travel associated legionnaires' disease in France, September 2001-August 2003. Euro Surveill 2004, 9 (http://www.eurosurveillance.org/em/v09n02/0902-224.asp)
2. Rota MC, Caporali MG, Massari M. European guidelines for Control and Prevention of Travel associated legionnaires' disease: the Italian experience. Euro Surveill 2004, 9 (http://www.eurosurveillance.org/em/v09n02/0902-223.asp)
3. Cano R, Prieto N, Martín C, Pelaz C, de Mateo S. Legionnaires' disease clusters associated with travel to Spain during the period January 2001 to July 2003. Euro Surveill 2004, 9 (http://www.eurosurveillance.org/em/v09n02/0902-225.asp)



Back to Table of Contents
en es fr it pt
Next

Disclamer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
Eurosurveillance [ISSN] - ©2008 All rights reserved